CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Correction: Leerink Partners Upgrades AN2 Therapeutics to Outperform From Market Perform, Adjusts Price Target to $9 From $1

Positive
AI Analysis

Summary

Leerink Partners upgraded AN2 Therapeutics to Outperform from Market Perform and raised its price target to $9 from $1.

Importance:3/10
Sentiment:
0.80
analyst_upgraderating_changeprice_target
Related Companies

Read the original article

Published by yahoo_finance on May 14, 2026 11:06 AM

Read Original